Does Omega-3 Lower Triglycerides?

TL;DR: Yes, omega-3 fatty acids — particularly EPA and DHA — are one of the most reliably effective nutritional interventions for lowering elevated triglycerides. At doses of 2–4 grams of EPA and DHA per day, research consistently shows reductions of 20–50% in people with high triglyceride levels.

Does Omega-3 Lower Triglycerides?

Yes — omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), have a well-established, dose-dependent effect on lowering triglycerides. This is one of the most consistent findings in cardiovascular nutrition research, and it forms the basis for FDA-approved prescription omega-3 therapies used to treat severe hypertriglyceridaemia. For people with elevated triglycerides, omega-3 supplementation is among the most evidence-backed non-statin interventions available.

High triglycerides are an independent risk factor for cardiovascular disease and are closely linked to insulin resistance, metabolic syndrome, and elevated ApoB particle count. Addressing triglyceride levels is therefore a meaningful part of any cardiometabolic health strategy. For broader context on managing lipid-related risk, see our guide on the best ApoB optimization plan.

How Omega-3 Reduces Triglycerides

Omega-3 fatty acids lower triglycerides through two complementary mechanisms.

Reduced hepatic triglyceride synthesis: EPA and DHA suppress the liver’s production of VLDL particles, which are the primary vehicles for transporting triglycerides in the bloodstream. They do this in part by activating PPAR-alpha, a nuclear receptor that shifts the liver toward fat oxidation rather than fat storage and export.

Enhanced triglyceride clearance: Omega-3s increase the activity of lipoprotein lipase, the enzyme responsible for breaking down triglycerides circulating in the blood. This accelerates the removal of triglyceride-rich particles from circulation.

Together, these effects reduce both the production and the persistence of triglycerides in the bloodstream. The result is a meaningful and measurable reduction in fasting triglyceride levels, particularly when baseline levels are elevated.

It is worth noting that while omega-3s reliably lower triglycerides, their effect on LDL cholesterol is more variable. High-dose DHA in particular can raise LDL particle size, and some individuals see a modest increase in LDL-C. This is less concerning when viewed alongside the reduction in triglycerides and VLDL, but it is worth monitoring — especially in the context of overall ApoB burden. If you want to understand how ApoB fits into the picture, our article on whether omega-3 reduces CRP provides additional context on its broader anti-inflammatory effects.

Dietary Sources vs. Supplements

Both dietary sources and concentrated supplements can raise EPA and DHA levels, but they are not equally practical for triglyceride management.

Fatty fish — such as salmon, mackerel, sardines, and herring — are the richest dietary sources of EPA and DHA. Eating two to three portions per week provides meaningful omega-3 intake and is consistently associated with better cardiovascular outcomes in observational studies. For most people with mildly elevated triglycerides, regular fatty fish consumption can contribute to improvement.

Supplements become relevant when dietary intake is insufficient or when triglyceride levels are significantly elevated and require a more targeted dose. Standard fish oil capsules typically contain 300–500mg of combined EPA and DHA per gram. Achieving the 2–4g therapeutic range therefore requires multiple capsules daily, or the use of higher-concentration formulations.

Prescription-strength omega-3 preparations — such as icosapent ethyl (EPA-only) or combined EPA/DHA formulations — are used specifically for severe hypertriglyceridaemia and deliver consistent, regulated doses. These are prescribed under medical supervision and have been studied in large cardiovascular outcome trials.

For practical purposes, a combined approach — regular fatty fish in the diet, supplemented when needed — is reasonable for most people looking to manage triglycerides as part of a broader cardiometabolic strategy.

What the Evidence Says

The evidence supporting omega-3s for triglyceride reduction is extensive and consistent across multiple study types.

Meta-analyses of randomised controlled trials show that EPA and DHA supplementation reduces fasting triglycerides by approximately 20–30% on average, with larger reductions — up to 45–50% — seen in individuals with very high baseline levels. The magnitude of reduction is strongly correlated with the starting triglyceride level: people with higher levels tend to see greater absolute benefit.

The American Heart Association and the European Society of Cardiology both recognise omega-3 fatty acids as an evidence-based intervention for elevated triglycerides. For very high triglycerides (above 5.6 mmol/L), guidelines in multiple countries recommend prescription omega-3 therapy as an adjunct to statins.

In the REDUCE-IT trial, high-dose icosapent ethyl (4g daily of EPA) reduced major cardiovascular events by 25% in statin-treated patients with elevated triglycerides and established cardiovascular disease or diabetes. However, this trial used a mineral oil placebo that may have inflated the apparent benefit, so the results remain somewhat contested. The cardiovascular benefit of omega-3s beyond triglyceride lowering is an active area of research.

For people with normal or near-normal triglyceride levels, the triglyceride-lowering effect of omega-3s is less pronounced — though other benefits, including modest anti-inflammatory effects, may still apply. Learn more in our complete guide to longevity.

Practical Guidance on Dosing and Use

For triglyceride reduction specifically, the effective therapeutic range is generally 2–4 grams of combined EPA and DHA per day. Lower doses (under 1g daily) show minimal triglyceride-lowering effect and are unlikely to produce meaningful change in people with elevated levels.

Key practical points:

  • Check the label carefully. Many standard fish oil capsules contain 1g of fish oil but only 300–500mg of EPA and DHA combined. To reach a therapeutic dose, the EPA and DHA content — not the total fish oil amount — is what matters.
  • Consistency matters. Triglyceride-lowering effects accumulate over weeks of regular use. Sporadic supplementation is unlikely to produce reliable results.
  • Take with food. Omega-3 absorption is improved when taken with a meal containing fat, and gastrointestinal side effects are reduced.
  • Consider EPA-dominant formulations if LDL management is also a concern, as high-dose DHA can modestly raise LDL-C in some individuals.
  • Consult a healthcare provider before starting high-dose omega-3 therapy, particularly if you are taking anticoagulants, as omega-3s have mild antiplatelet effects.

Omega-3 supplementation works best when combined with broader lifestyle changes. Reducing refined carbohydrates and added sugars, moderating alcohol intake, and improving insulin sensitivity through exercise all have independent and additive effects on triglyceride levels. If insulin resistance is contributing to elevated triglycerides, addressing that root cause is important — a topic explored further in our article on whether insulin resistance raises ApoB.

Limitations and Considerations

While the triglyceride-lowering evidence for omega-3s is strong, several limitations are worth understanding.

Effect size depends on baseline levels. Omega-3s produce the largest relative reductions in people who start with significantly elevated triglycerides. Those with already-normal levels will see modest or negligible changes.

LDL effects are variable. High-dose DHA supplementation can modestly raise LDL-C in some people. This does not appear to increase cardiovascular risk when triglycerides are falling and VLDL is reduced, but it is worth tracking, particularly in the context of ApoB.

Supplement quality varies. Fish oil supplements are prone to oxidation, which can reduce efficacy and potentially produce harmful byproducts. Choosing third-party tested, high-concentration formulations stored properly helps mitigate this.

Omega-3s are not a standalone intervention. For significantly elevated triglycerides, dietary change — particularly reducing refined carbohydrates, sugar, and alcohol — is equally or more important than supplementation alone. Omega-3s work best as part of a comprehensive cardiometabolic approach.

References

Authoritative Sources

Frequently Asked Questions

How much can omega-3 lower triglycerides?

At doses of 2–4g of EPA and DHA per day, research consistently shows triglyceride reductions of 20–50%. The effect is larger in people who start with significantly elevated levels. At lower doses, the reduction is modest and may not be clinically meaningful.

Can I lower triglycerides with food alone, or do I need supplements?

For mildly elevated triglycerides, regular consumption of fatty fish — two to three portions per week — can contribute meaningfully to reduction. For more significantly elevated levels, dietary sources alone are unlikely to deliver a sufficient therapeutic dose, and supplementation is typically needed to reach the 2–4g EPA/DHA range required for a strong clinical effect.

Are there side effects from taking omega-3 to lower triglycerides?

Omega-3 supplements are generally well tolerated. The most common side effects at higher doses are gastrointestinal — including fishy aftertaste, nausea, or loose stools — which can often be reduced by taking supplements with food or using enteric-coated formulations. High-dose omega-3s have mild antiplatelet effects, so caution is warranted if you are taking anticoagulant medications. Speak to a healthcare provider before starting high-dose therapy.

Does lowering triglycerides with omega-3 reduce cardiovascular risk?

Elevated triglycerides are associated with increased cardiovascular risk, and reducing them is a clinically meaningful goal. Evidence from large trials such as REDUCE-IT suggests high-dose EPA can reduce major cardiovascular events in high-risk patients, though the magnitude of benefit from triglyceride lowering alone remains debated. Omega-3s appear to have additional effects — including modest anti-inflammatory actions — that may contribute independently to cardiovascular protection.

Is omega-3 a reliable method for managing high triglycerides long-term?

Yes, when used consistently at an appropriate dose, omega-3 supplementation is a well-supported, long-term strategy for managing elevated triglycerides. It works best as part of a broader approach that includes reducing refined carbohydrates and sugar, moderating alcohol, and addressing any underlying insulin resistance. For very high triglycerides, prescription omega-3 therapy under medical supervision is often appropriate.

Conclusion

Omega-3 fatty acids — particularly EPA and DHA — are one of the most evidence-backed nutritional interventions for lowering triglycerides. At therapeutic doses of 2–4g per day, research consistently demonstrates reductions of 20–50%, with the largest effects seen in people with significantly elevated baseline levels. The mechanisms are well understood: omega-3s reduce hepatic triglyceride production and accelerate clearance from the bloodstream.

For most people, a practical approach combines regular fatty fish consumption with targeted supplementation when dietary intake is insufficient or triglyceride levels require more aggressive management. Omega-3s are not a standalone solution — dietary quality, carbohydrate intake, alcohol, and insulin sensitivity all influence triglyceride levels independently — but they are a reliable and well-tolerated tool within a broader cardiometabolic strategy.

Find out more about omega-3 and triglycerides

Search for more resources and information:

Similar Posts